CENTRAL IOWA HEALTH SYSTEM has a total of 12 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Australia, China and United States. Its main competitors in its focus markets pharmaceuticals, agriculture and biotechnology are APTIMMUNE BIOLOGICS INC, ANIMAL TECHNOLOGY INST TAIWAN and AGRICULTURAL BIOTECHNOLOGY CT.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | China | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Hong Kong | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Agriculture | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Animal care | |
#4 | Microorganisms | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Rossi Gabriela | 8 |
#2 | Seregina Tatiana | 8 |
#3 | Link Charles J Jr | 7 |
#4 | Link Jr Charles J | 2 |
#5 | Liu Hsi-Chou | 2 |
#6 | Singer Patricia A | 2 |
#7 | Gabriela Link Charles J Jr Ser | 1 |
#8 | Link Charles J Jr J | 1 |
#9 | Gabriela Rossi | 1 |
Publication | Filing date | Title |
---|---|---|
US2014072597A1 | Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase | |
MXPA05003705A | Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase. | |
WO2004018625A2 | Ovarian cancer-specific promoter |